[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
January 2002

AREDS Investigators Distort Findings

Arch Ophthalmol. 2002;120(1):100. doi:

In my opinion, the Age-Related Eye Disease Study (AREDS) investigators promoted a nonsignificant result into a conclusive recommendation.1 Here is how they did it.

The primary study outcomes for AREDS are explicitly stated in the "Participants and Methods" section of the article: (1) progression to advanced age-related macular degeneration (AMD) and (2) a 15-letter decrease in visual acuity. These outcomes were to be evaluated in all patients by independent tests of significance of the 2 primary treatments. This carefully specified primary analysis led to 4 tests, none of which was statistically significant. One, testing the effect of zinc on progression to advanced AMD, achieved a level of significance defined by the investigators as suggestive.

First Page Preview View Large
First page PDF preview
First page PDF preview
×